Filing Flows › Champions Oncology (CSBR) › Capital expenditures
Champions Oncology (CSBR) capital expenditures by quarter
Champions Oncology's capital expenditures were $46K in Q1 FY26 (first quarter fiscal 2026), -82% from Q4 FY25. Over the last 3 quarters it ranged from $42K (Q3 FY25) to $253K (Q4 FY25).
| Quarter | Capital expenditures | Q/Q | Y/Y |
|---|---|---|---|
| Q1 FY26 | $46K | -82% | — |
| Q4 FY25 | $253K | +502% | — |
| Q3 FY25 | $42K | — | — |
Q1 FY26 at a glance
Champions Oncology, Q1 FY26: revenue $14.0M (-0.5% year over year), operating margin -3.8%, net loss $466K, operating cash flow $600K. The chart follows the revenue to costs, profit and cash.
Questions
What is Champions Oncology's capital expenditures?
Champions Oncology's capital expenditures were $46K in Q1 FY26 (first quarter fiscal 2026), -82% from Q4 FY25.
How has Champions Oncology's capital expenditures changed?
Over the last 3 quarters it ranged from $42K (Q3 FY25) to $253K (Q4 FY25).